Table 6.
Vaccine Effectiveness in the Influenza-Active Season
Influenza Virus Subtype | No. | Odds Ratio (95% CI) | VE, % (95% CI)a |
---|---|---|---|
2011–2012 | |||
All influenza subtypes | 122 | 0.268 (.097–.738) | 73 (26 to –90) |
Only influenza virus type A(H3N2) | 121 | 0.288 (.103–.806) | 71 (19 to –90) |
2012–2013 | |||
All influenza subtypes | 206 | 0.493 (.262–.928) | 51 (7–74) |
Only influenza virus type A | 178 | 0.423 (.211–.850) | 58 (15–79) |
Only influenza virus type A(H3N2) | 154 | 0.330 (.137–.796) | 67 (20–86) |
Only influenza virus type A(H1N1)pdm09 | 137 | 0.466 (.179–1.215) | 53 (–22 to 82) |
Only influenza virus type B | 141 | 0.570 (.203–1.600) | 43 (–60 to 80) |
Only influenza virus type B/Yamagata | 136 | 0.935 (.286–3.056) | 7 (–205 to 71) |
For more details, see Supplementary Table 3.
Abbreviations: CI, confidence interval; VE, vaccine effectiveness.
aCorrected for the possible confounders age group, comorbidity, sex, and smoking. Data were calculated for the influenza-active period in the Netherlands as defined by the Netherlands Institute for Health Services Research [11].